SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5me3'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E71_M_ASCM995_0
(MYROSINASE MA1)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 7 ILE A 884
PHE A 865
PHE A 862
PHE A 921
 None
 1.05A 1e71M-5me3A:
undetectable		 1e71M-5me3A:
19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E72_M_ASCM995_0
(MYROSINASE MA1)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 7 ILE A 884
PHE A 865
PHE A 862
PHE A 921
 None
 1.04A 1e72M-5me3A:
undetectable		 1e72M-5me3A:
19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EE2_B_CHDB1250_0
(ALCOHOL
DEHYDROGENASE)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		3 / 3 MET A 919
LEU A 922
SER A 923
 None
 0.64A 1ee2A-5me3A:
undetectable		 1ee2A-5me3A:
15.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LHV_A_NOGA301_1
(SEX HORMONE-BINDING
GLOBULIN)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 8 SER A1253
ASP A1209
ASN A1211
LEU A1241
 None
 1.10A 1lhvA-5me3A:
undetectable		 1lhvA-5me3A:
9.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OS6_A_DXCA75_0
(PPCA)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 8 ILE A 486
LEU A 490
PHE A 504
GLY A 555
 None
 0.79A 1os6A-5me3A:
undetectable		 1os6A-5me3A:
4.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RK3_A_VDXA500_1
(VITAMIN D3 RECEPTOR)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 TYR A1248
LEU A1241
VAL A1238
SER A1253
LEU A1198
 None
 1.41A 1rk3A-5me3A:
undetectable		 1rk3A-5me3A:
14.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1S9P_C_DESC500_1
(ESTROGEN-RELATED
RECEPTOR GAMMA)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 LEU A1049
LEU A1052
ALA A1053
LEU A1023
ILE A1098
 None
 1.07A 1s9pC-5me3A:
undetectable		 1s9pC-5me3A:
12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YA3_A_STRA1001_2
(MINERALOCORTICOID
RECEPTOR)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 4 LEU A 976
LEU A1001
SER A1002
LEU A 984
 None
 1.15A 1ya3A-5me3A:
2.3		 1ya3A-5me3A:
13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXP_A_P1ZA3001_1
(SERUM ALBUMIN)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 LEU A 801
LEU A 852
ALA A 849
ILE A 848
ALA A 794
 None
 1.10A 2bxpA-5me3A:
undetectable		 2bxpA-5me3A:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2E7F_A_C2FA3000_0
(5-METHYLTETRAHYDROFO
LATE CORRINOID/IRON
SULFUR PROTEIN
METHYLTRANSFERASE)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 MET A 719
LEU A 535
GLY A 560
SER A 561
ILE A 563
 None
 1.26A 2e7fA-5me3A:
undetectable		 2e7fA-5me3A:
13.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2M9Q_B_BEZB251_0
(SERINE PROTEASE
INHIBITOR
SERINE PROTEASE
SUBUNIT NS2B, SERINE
PROTEASE NS3)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 9 LEU A1345
ILE A1453
PHE A1291
VAL A1399
THR A1400
 None
 1.03A 2m9qA-5me3A:
undetectable		 2m9qA-5me3A:
11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 11 SER A 437
LEU A 517
ILE A 433
ARG A 529
LEU A 527
 None
 1.38A 2v0mA-5me3A:
0.0		 2v0mA-5me3A:
18.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3B_B_FOLB401_1
(DIHYDROFOLATE
REDUCTASE)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		3 / 3 GLU A 813
GLN A 781
ARG A 822
 None
 0.94A 2w3bB-5me3A:
undetectable		 2w3bB-5me3A:
10.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XKW_A_P1BA1478_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 7 LEU A 958
GLU A 994
ILE A 983
ALA A1020
 None
 0.85A 2xkwA-5me3A:
undetectable		 2xkwA-5me3A:
13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XKW_B_P1BB1475_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 ILE A 744
CYH A 708
ARG A 707
LEU A 553
ILE A 706
 None
 1.18A 2xkwB-5me3A:
undetectable		 2xkwB-5me3A:
13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YGP_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 LEU A1359
ILE A1351
LEU A1298
VAL A1366
PHE A1324
 None
 1.12A 2ygpA-5me3A:
undetectable		 2ygpA-5me3A:
10.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZLC_A_VDXA500_1
(VITAMIN D3 RECEPTOR)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 TYR A1248
LEU A1241
VAL A1238
SER A1253
LEU A1198
 None
 1.41A 2zlcA-5me3A:
undetectable		 2zlcA-5me3A:
14.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3C6G_A_VD3A701_2
(CYTOCHROME P450 2R1)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		3 / 3 MET A1411
VAL A1366
GLU A1406
 None
 0.90A 3c6gA-5me3A:
undetectable		 3c6gA-5me3A:
16.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_A_1N1A2000_1
(P38A)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 VAL A1082
ARG A1058
ILE A1109
ILE A1098
ALA A1033
 None
 1.16A 3ohtA-5me3A:
2.9
3ohtB-5me3A:
2.8		 3ohtA-5me3A:
17.18
3ohtB-5me3A:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SEL_X_DXCX75_0
(CYTOCHROME C7)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 8 ILE A 486
LEU A 490
PHE A 504
GLY A 555
 None
 0.81A 3selX-5me3A:
undetectable		 3selX-5me3A:
4.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SJ1_X_DXCX75_0
(CYTOCHROME C7)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 6 ILE A 486
LEU A 490
PHE A 504
GLY A 555
 None
 0.79A 3sj1X-5me3A:
undetectable		 3sj1X-5me3A:
4.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U52_A_CUA515_0
(PHENOL HYDROXYLASE
COMPONENT PHL
PHENOL HYDROXYLASE
COMPONENT PHN)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		3 / 3 HIS A1292
HIS A1346
ILE A1342
 None
 0.75A 3u52A-5me3A:
undetectable
3u52C-5me3A:
undetectable		 3u52A-5me3A:
17.29
3u52C-5me3A:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UPR_A_1KXA277_1
(HLA CLASS I
HISTOCOMPATIBILITY
ANTIGEN, B-57 ALPHA
CHAIN)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 10 TYR A 795
ILE A 800
VAL A 796
TYR A 758
ILE A 782
 None
 1.42A 3uprA-5me3A:
undetectable		 3uprA-5me3A:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UPR_C_1KXC277_1
(HLA CLASS I
HISTOCOMPATIBILITY
ANTIGEN, B-57 ALPHA
CHAIN)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 10 TYR A 795
ILE A 800
VAL A 796
TYR A 758
ILE A 782
 None
 1.38A 3uprC-5me3A:
undetectable		 3uprC-5me3A:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VT3_A_VDXA500_1
(VITAMIN D3 RECEPTOR)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 TYR A1248
LEU A1241
VAL A1238
SER A1253
LEU A1198
 None
 1.41A 3vt3A-5me3A:
undetectable		 3vt3A-5me3A:
13.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VT7_A_VDXA500_1
(VITAMIN D3 RECEPTOR)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 TYR A1248
LEU A1241
VAL A1238
SER A1253
LEU A1198
 None
 1.37A 3vt7A-5me3A:
undetectable		 3vt7A-5me3A:
14.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DV1_A_SRYA1601_1
(16S RRNA
RIBOSOMAL PROTEIN
S12)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		3 / 3 LYS A 974
LYS A 972
PRO A 973
 None
 1.18A 4dv1L-5me3A:
undetectable		 4dv1L-5me3A:
7.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EQ4_A_SALA601_1
(4-SUBSTITUTED
BENZOATES-GLUTAMATE
LIGASE GH3.12)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 7 LEU A 517
THR A 513
ILE A 433
GLY A 428
 None
 0.93A 4eq4A-5me3A:
undetectable		 4eq4A-5me3A:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EQL_A_SALA602_1
(4-SUBSTITUTED
BENZOATES-GLUTAMATE
LIGASE GH3.12)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 7 LEU A 517
THR A 513
ILE A 433
GLY A 428
 None
 0.94A 4eqlA-5me3A:
undetectable		 4eqlA-5me3A:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EQL_B_SALB602_1
(4-SUBSTITUTED
BENZOATES-GLUTAMATE
LIGASE GH3.12)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 7 LEU A 517
THR A 513
ILE A 433
GLY A 428
 None
 0.96A 4eqlB-5me3A:
undetectable		 4eqlB-5me3A:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HBF_A_DXCA75_0
(PPCA)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 7 ILE A 486
LEU A 490
PHE A 504
GLY A 555
 None
 0.83A 4hbfA-5me3A:
undetectable		 4hbfA-5me3A:
4.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HC3_A_DXCA75_0
(PPCA)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 7 ILE A 486
LEU A 490
PHE A 504
GLY A 555
 None
 0.75A 4hc3A-5me3A:
undetectable		 4hc3A-5me3A:
4.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OR0_A_NPSA603_1
(SERUM ALBUMIN)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 11 LEU A 689
SER A 692
LEU A 709
LEU A 535
LEU A 693
 None
 1.36A 4or0A-5me3A:
undetectable		 4or0A-5me3A:
19.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OR0_B_NPSB603_1
(SERUM ALBUMIN)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 11 LEU A 689
SER A 692
LEU A 709
LEU A 535
LEU A 693
 None
 1.33A 4or0B-5me3A:
undetectable		 4or0B-5me3A:
19.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_C_HQEC503_1
(CATALASE)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 8 PHE A1315
LEU A1272
LEU A1298
PHE A1297
 None
 0.95A 4qopC-5me3A:
undetectable		 4qopC-5me3A:
17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y8W_B_STRB603_1
(CYTOCHROME P450
21-HYDROXYLASE)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 LEU A 531
ILE A 559
GLY A 560
VAL A 690
LEU A 553
 None
 1.12A 4y8wB-5me3A:
undetectable		 4y8wB-5me3A:
18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z2E_F_TR6F101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
SYMMETRIZED E-SITE
DNA)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 5 GLY A1275
ARG A1277
GLY A1279
GLU A1281
 None
 1.09A 4z2eB-5me3A:
undetectable
4z2eC-5me3A:
undetectable		 4z2eB-5me3A:
18.10
4z2eC-5me3A:
13.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 LEU A1241
LEU A1344
PHE A1297
THR A1242
THR A1322
 None
 1.18A 5bykA-5me3A:
undetectable		 5bykA-5me3A:
13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DWK_C_ACTC207_0
(DIACYLGLYCEROL
KINASE)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 5 GLU A1393
ALA A1392
GLU A1335
ASN A1333
 None
 1.43A 5dwkC-5me3A:
2.5		 5dwkC-5me3A:
7.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FUK_A_SNPA1236_1
(MROUPO)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		4 / 7 ILE A 706
ILE A 713
THR A 728
ILE A 729
 None
 0.70A 5fukA-5me3A:
undetectable
5fukB-5me3A:
undetectable		 5fukA-5me3A:
12.18
5fukB-5me3A:
12.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5GS4_A_ESTA603_1
(ESTROGEN RECEPTOR)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 12 THR A1054
LEU A1052
ALA A1053
ILE A1098
LEU A1086
 None
 0.96A 5gs4A-5me3A:
undetectable		 5gs4A-5me3A:
12.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IKT_B_TLFB601_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		3 / 3 TYR A 438
TYR A 601
SER A 605
 None
 0.92A 5iktB-5me3A:
0.9		 5iktB-5me3A:
19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M35_B_BEZB302_0
(14-3-3 PROTEIN
ZETA/DELTA)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		3 / 3 MET A1411
GLN A1414
ARG A1409
 None
 1.13A 5m35B-5me3A:
4.1		 5m35B-5me3A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M36_A_BEZA303_0
(14-3-3 PROTEIN
ZETA/DELTA)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		3 / 3 MET A1411
GLN A1414
ARG A1409
 None
 1.10A 5m36A-5me3A:
4.4		 5m36A-5me3A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MZP_A_CFFA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 9 VAL A1369
PHE A1324
MET A1362
LEU A1345
ILE A1341
 None
 1.46A 5mzpA-5me3A:
1.7		 5mzpA-5me3A:
15.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5U98_A_1KXA301_1
(HLA CLASS I
HISTOCOMPATIBILITY
ANTIGEN, B-57 ALPHA
CHAIN)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 10 TYR A 795
ILE A 800
VAL A 796
TYR A 758
ILE A 782
 None
 1.40A 5u98A-5me3A:
undetectable		 5u98A-5me3A:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5U98_D_1KXD301_1
(HLA CLASS I
HISTOCOMPATIBILITY
ANTIGEN, B-57 ALPHA
CHAIN)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 10 TYR A 795
ILE A 800
VAL A 796
TYR A 758
ILE A 782
 None
 1.41A 5u98D-5me3A:
undetectable		 5u98D-5me3A:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6D9H_R_ADNR400_1
(CHIMERA PROTEIN OF
MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4 AND
ADENOSINE RECEPTOR
A1)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		5 / 10 VAL A1369
PHE A1324
MET A1362
LEU A1345
ILE A1341
 None
 1.29A 6d9hR-5me3A:
3.7		 6d9hR-5me3A:
7.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FNA_B_BEZB302_0
(14-3-3 PROTEIN
ZETA/DELTA)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		3 / 3 MET A1411
GLN A1414
ARG A1409
 None
 1.14A 6fnaB-5me3A:
3.6		 6fnaB-5me3A:
12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FNB_A_BEZA301_0
(14-3-3 PROTEIN
ZETA/DELTA)		 5me3 SISTER CHROMATID
COHESION PROTEIN 2
(Eremothecium
gossypii) 		3 / 3 MET A1411
GLN A1414
ARG A1409
 None
 1.13A 6fnbA-5me3A:
3.3		 6fnbA-5me3A:
12.38